BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11501779)

  • 1. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
    Yüce K; Baykal C; Genç C; Al A; Ayhan A
    Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer.
    Boran N; Kayikçioğlu F; Yalvaç S; Tulunay G; Ekinci U; Köse MF
    Gynecol Obstet Invest; 2000; 49(4):272-4. PubMed ID: 10828712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal fluid analysis in the differentiation of ovarian cancer and benign ovarian tumor.
    Halperin R; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 1999; 20(1):40-4. PubMed ID: 10422681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia.
    Kucukgoz Gulec U; Paydas S; Guzel AB; Buyukkurt S; Seydaoglu G; Vardar MA
    Med Oncol; 2012 Dec; 29(4):2937-43. PubMed ID: 22274916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
    Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
    Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
    Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
    Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade.
    Simaga S; Osmak M; Babic D; Sprem M; Vukelic B; Abramic M
    Int J Gynecol Cancer; 2005; 15(3):438-44. PubMed ID: 15882167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical activity in peritoneal effusion of ovarian malignancy].
    Yoshioka M; Yasuda M; Tabira K; Isonishi S; Murae M; Nakabayashi Y; Inui H; Morimoto O; Terashima Y; Hachiya S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):871-9. PubMed ID: 2426375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
    Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
    Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of CA125 and LDH assays in assisting diagnosis of epithelial ovarian carcinoma].
    Qie M; Peng Z; Cao Z; Tang Q; He B
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):310-3. PubMed ID: 9389070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination.
    Chechlinska M; Kaminska J; Markowska J; Kramar A; Steffen J
    Int J Biol Markers; 2007; 22(3):172-80. PubMed ID: 17922459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal Nodules in a Pediatric Patient with Benign Teratoma. A Case Report and Review of Literature.
    Badru F; Saxena S; Munoz-Abraham AS; Guzman MA; Bansal S; Chatoorgoon K
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):632-636. PubMed ID: 29990549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.
    Miao R; Badger TC; Groesch K; Diaz-Sylvester PL; Wilson T; Ghareeb A; Martin JA; Cregger M; Welge M; Bushell C; Auvil L; Zhu R; Brard L; Braundmeier-Fleming A
    PLoS One; 2020; 15(1):e0227707. PubMed ID: 31917801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bendifallah S; Body G; Daraï E; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine deaminase activity in patients with ovarian neoplasms.
    Urunsak IF; Gulec UK; Paydas S; Seydaoglu G; Guzel AB; Vardar MA
    Arch Gynecol Obstet; 2012 Jul; 286(1):155-9. PubMed ID: 22395862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum alpha-hydroxybutyrate dehydrogenase in patients with ovarian carcinoma.
    Kikuchi Y; Momose E; Kizawa I; Kuki E; Kato K
    Acta Obstet Gynecol Scand; 1985; 64(7):553-6. PubMed ID: 4082930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.